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Abstract
Background: Automated procedures are increasingly used in cancer registration, and it is important that
the data produced are systematically checked for consistency and accuracy. We evaluated an automated
procedure for cancer registration adopted by the Lombardy Cancer Registry in 1997, comparing
automatically-generated diagnostic codes with those produced manually over one year (1997).
Methods: The automatically generated cancer cases were produced by Open Registry algorithms. For
manual registration, trained staff consulted clinical records, pathology reports and death certificates. The
social security code, present and checked in both databases in all cases, was used to match the files in the
automatic and manual databases. The cancer cases generated by the two methods were compared by
manual revision.
Results: The automated procedure generated 5027 cases: 2959 (59%) were accepted automatically and
2068 (41%) were flagged for manual checking. Among the cases accepted automatically, discrepancies in
data items (surname, first name, sex and date of birth) constituted 8.5% of cases, and discrepancies in the
first three digits of the ICD-9 code constituted 1.6%. Among flagged cases, cancers of female genital tract,
hematopoietic system, metastatic and ill-defined sites, and oropharynx predominated. The usual reasons
were use of specific vs. generic codes, presence of multiple primaries, and use of extranodal vs. nodal
codes for lymphomas. The percentage of automatically accepted cases ranged from 83% for breast and
thyroid cancers to 13% for metastatic and ill-defined cancer sites.
Conclusion: Since 59% of cases were accepted automatically and contained relatively few, mostly trivial
discrepancies, the automatic procedure is efficient for routine case generation effectively cutting the
workload required for routine case checking by this amount. Among cases not accepted automatically,
discrepancies were mainly due to variations in coding practice.
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Background
The data provided by cancer registries are vital for public
health surveillance, health service planning, evaluation of
the impact of interventions on cancer incidence and sur-
vival, clinical auditing, and epidemiological research.
They also provide information useful for health promo-
tion and genetic counseling. To fulfill these functions ade-
quately, the data produced by cancer registries must be of
high quality [1]. Incomplete and inaccurate data registra-
tion may introduce serious bias to estimates of cancer sur-
vival [2,3] and cancer incidence rates [4-6].
Advances in information technology have influenced all
aspects of health care. In the field of cancer registration,
electronic data transfer reduces transcription errors,
reduces the need for manual data extraction, promises to
reduce the time required to publish and analyze data, and
is generally more cost-effective than traditional manual
methods. It has thus become feasible to generate cancer
incidence data automatically from electronically trans-
ferred data using computer programs, with further savings
of time and manpower. It is important, however, to verify
the accuracy and consistency of the automatically-pro-
duced data.
In the present study we have validated automated registra-
tion by comparison with manual registration for an entire
incidence year. The first advantage of this comparison
method is that it evaluates the entire automated registra-
tion procedure, including source acquisition, record link-
age and algorithm function. Each of these procedures may
be associated with inaccuracies which influence the over-
all accuracy of the automated process. The second advan-
tage of the method is that it avoids bias due case sampling
(or re-abstraction) as it considers virtually all incident
cases in the year.
In 1997 the Lombardy Cancer Registry (LCR), Province of
Varese, northern Italy, introduced a computerized auto-
mated procedure (Open Registry) to generate cancer inci-
dence data from electronically transferred source files. In
the present study, we examine the consistency and accu-
racy of the automatically generated data by comparison
with the manually generated cancer incidence data for the
same Varese population in 1997.
Methods
Manual registration
Data sources for manual registration were clinical records,
pathology reports and death certificates. Trained staff con-
sulted clinical records and pathology reports in the
archives of the hospitals and pathology laboratories of the
Province of Varese and in selected institutes of neighbor-
ing Provinces, abstracting the data onto case forms.
Printed death certificates arrived directly from the local
health authority.
The items abstracted were demographic data, tumor site,
date of diagnosis, nature of diagnostic confirmation, and
tumor type according to the International Classification
of Disease (ICD-9, WHO 1975, for topography) and Inter-
national Classification of Disease for Oncology (ICDO-2,
WHO 1990, for morphology). Where possible, death cer-
tificate only (DCO) cases were validated by back-tracing
clinical records and pathology reports. Registrations were
routinely checked for consistency by medical staff.
The LCR is tumor-based: multiple primaries occurring in
a patient are recorded separately if they differ morpholog-
ically (ICDO-2) or occur at different anatomical sites
(third digit of ICD-9 site code). In 1976–1997, 84% of
cases were verified microscopically. The percentage of
DCO cases is on average 2% of the new cancer cases regis-
tered in any year [9-11]. These indicators suggest that the
LCR data are of acceptable quality.
Automatic registration
The data sources are hospital discharge files and death cer-
tificates (both containing ICD-9 codes) and pathology
reports, containing SNOMED codes (version 2, 1979)
[12]. These records were designed, and are collected, for
purposes other than cancer registration. Electronic files
containing these data are sent periodically to the LCR. The
Open Registry software translates the SNOMED codes to
ICD-9 (1975) codes by using a translation system devel-
oped in-house and incorporated into the Open Registry
software. Open Registry then links the records of the
sources files to aggregate information for person. This is
done using deterministic and probabilistic methods [13].
Finally data consistency checks are performed, again by
ad-hoc routines within Open Registry.
The incidence data are then generated by Open Registry
from algorithms acting on the ICD-9 codes now present
for each case in each of the source files. The strategy imple-
mented by the algorithms is to choose the best code from
the ones that might be available for each case. The inci-
dence data are generated in three steps:
Step 1
The following algorithms are applied in sequence:
￿ Algorithm (a) (concordant code check). This algorithm
checks whether the first three digits of the ICD-9 code
agree in all source records. If they do, all records for the
case are considered fully concordant and the computation
stops; if not the algorithm passes the case records to algo-
rithm (b).Population Health Metrics 2006, 4:10 http://www.pophealthmetrics.com/content/4/1/10
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￿ Algorithm (b) (elimination of generic site codes). If the
codes are split between site-specific and generic ones, the
algorithm attempts to eliminate the generic code (e.g. 146
over 1499) using a hierarchic table developed in-house,
linking specific and generic sites, and also using if neces-
sary the information provided by the fourth digit. If after
eliminations, all the remaining codes now agree the case
is considered concordant and the computation stops; oth-
erwise the algorithm passes the case records to algorithm
(c).
￿ Algorithm (c) (elimination of metastatic and ill-defined
site codes). The algorithm eliminates metastatic site codes
when compatible generic or specific codes are present
(e.g. 1970 over 162). If the remaining codes are now the
same the case is considered concordant; otherwise it is
tagged as not concordant.
Step 2
New case records generated in step 1 are checked against
those already in the LCR database to identify cases with
and without a previous cancer diagnosis; the former
might be multiple cancer cases. For cases without a previ-
ous cancer diagnosis, one of three categories is assigned by
Open Registry:
￿ concordant multiple incident
￿ unique incident
￿ non-concordant multiple incident.
For cases with a previous cancer diagnosis, Open Registry
assigns one of the following categories:
￿ previous concordant
￿ previous non-concordant.
Previous concordant cases are those for which all incident
codes past and present are concordant.
Step 3
Decision on automatic acceptance
The program is set up to automatically accept records
assigned as concordant multiple incident and also those
with a single instance (i.e. status unique incident) of code
173 (non-melanoma skin cancer) on a pathology report.
Records assigned non-concordant multiple incident or
unique incident with code other than 173 on the pathol-
ogy report, are tagged for manual review.
A flow chart illustrating the entire procedure is shown in
Figure 1. Previous concordant cases do not result in a
change in the LCR database. Previous non-concordant
cases are reviewed manually.
Example 1
A case with 153 (colon cancer) on the pathology report,
153 and 197 (secondary cancer of respiratory and diges-
tive systems) on the hospital discharge form, and 159.9
(cancer of ill-defined site within digestive organs) on the
death certificate is passed to algorithm (b) and algorithm
(c), which eliminate codes 159.9 and 197, leaving two
instances of code 153 (colon). The case is automatically
accepted as concordant multiple incident.
Example 2
Code 182 (body of uterus cancer) on pathology report of
1997; code 174 (female breast cancer) in LCR database
incident in 1995. Such cases are assigned to category pre-
vious non-concordant and flagged for manual checking.
Data comparison
It was found that 2959 (59%) automatically generated
cancer cases were accepted by Open Registry because the
ICD-9 codes were concordant from all data sources, while
2068 (41%) were flagged for manual verification as the
codes were not concordant, or because there was a unique
incident code. We carried out comparisons on both the
automatically accepted cases (first level comparison) and
on the cases flagged for manual checking (second level
comparison).
The aim of the first level comparison was to determine the
extent of agreement between the automatic and manually
produced site codes, and thereby provide an assessment of
the quality of the automated case generation procedure.
The second level comparison was carried out to determine
the reasons why cases could not be generated automati-
cally: this involved manual comparison of the disease
code or codes of each flagged case with the code produced
manually. The social security code, present and checked in
both databases in all cases, was used to match the files in
the automatic and manual databases.
Results
First level comparison
Identifying and demographic data
Among 2959 automatically accepted cases we had 1.6%
surname discrepancies, 2.8% first name discrepancies,
0.07% sex assignment discrepancies, 1.2% date of birth
discrepancies, and 2.8% residence code discrepancies
(Table 1). The two sex misclassifications almost certainly
arose from sexually ambiguous first names. The date of
birth discrepancies regarded the year in 6 patients, the
month in 7 patients, and the day in 24 patients. All the
residence code discrepancies nevertheless placed the casePopulation Health Metrics 2006, 4:10 http://www.pophealthmetrics.com/content/4/1/10
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within the Province of Varese. Most of the discrepancies
were trivial and none would have disturbed the record
linkage performed by the Epilink module [13] of Open
Registry.
Site discrepancies
Among the cases accepted automatically, the site code dif-
fered from that in the corresponding manually generated
incidence case for 1.6% of records. Table 2 categorizes the
discrepancies found. Many of the site code discrepancies
arose as a result of codification of adjacent sites (e.g. sig-
moid colon instead of rectum, biliary system instead of
liver) or by codification of a specific primary site instead
of metastases or vice versa (e.g. liver metastases instead of
primary liver cancer). In seven cases, aspecific hematopoi-
etic system codes were used, whereas the manually-gener-
ated case had more specific codes (see Table 2).
Second level comparison
The second level comparison was carried out on the 2068
cases flagged by Open Registry as requiring manual check-
ing. The percentage of automatically accepted cases varied
with cancer site (Table 3). Among common malignancies,
oropharyngeal cancers (codes 140–149), cancers of non-
thyroid endocrine glands (code 194) and cancers of
female genital organs (codes 179–184) were characterized
by high proportions requiring manual checking. Among
the rare cancers, those of the eye (code 190), peritoneum
and abdominal cancers, and also ill-defined, metastatic
and unspecified site cancers (codes 158–159, 195–199,
respectively) had high proportions requiring manual
checking. Close to 50% of pleural cancer (code 163), bone
and soft tissue cancers (codes 170 and 171), skin
melanoma (code 172), and lymphoma (codes 200–202)
were accepted automatically.
Flowchart of automatic case resolution Figure 1
Flowchart of automatic case resolution
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By contrast, female breast cancer (code 174) and thyroid
cancer (code 193) were characterized by high automatic
acceptance rate, with only 17% of cases requiring check-
ing.
Table 4 lists the problems found in the flagged cases.
Nearly half of the melanoma cases (code 172) had one
source code only and for this reason were automatically
flagged for manual checking. There was a single data
source also for 48.8% of the flagged leukaemia cases
(codes 204–208) and 43% of the 14 peritoneal, retroperi-
toneal and abdominal cancers (codes 158 and 159).
One of the most common reasons for flagging was that
the codes differed between the various source records. The
codes could differ yet with reference to sites within a sin-
gle organ system (examples: codes 153 and 159 digestive
tract cancers; codes 200 and 208 hematopoietic system
cancers); or could involve different organ systems (exam-
ples: code 200 hematopoietic system and 151 digestive
organs; code 170 bone and code 162 respiratory organs).
The presence of different codes referring to a single organ
system did not usually indicate a major discrepancy. For
example, many oropharyngeal cancer cases had two or
more codes (typically 145 and 146) indicating adjacent
regions within the oral cavity. Among the discrepant lym-
phomas, many were due to coding at an extranodal site
(e.g. stomach, testis or tonsil; codes 151, 186 and 146
respectively) rather than as a lymphoma (codes 200–
202). (Table 4)
When discrepant codes referred to distinct organ systems,
the most commonly involved codes were: malignancy of
other and ill defined sites (code 195), metastasis (codes
196–198), unspecified site (code 199) and malignancy of
female genital tract (codes 179–184).
For example, code 199 often accompanied code 155 (pri-
mary liver), but following histological confirmation, the
more correct code 197 (metastatic liver disease) replaced
codes 155 and 199 in subsequent records (data not
shown).
Discussion
Although the need for quality control of cancer registra-
tion data is recognized [14] few data exist on quality of
automated cancer registration procedures. Assessments of
accuracy using mainly automated methods are available
for Arhus County, Denmark [7]; Veneto [8] and Ontario,
Canada [7]. The approach in Arhus County was to com-
pare the automatic data with those gathered manually by
the Danish national cancer registry. Details of the compar-
ison by site are not available. The approach in Ontario
was to re-abstract the data. For Arhus County the reported
accuracy level was 98.6% for all cancer sites, and for
Ontario the agreement between manual and computer
assisted diagnosis was 93.3%. Both these figures are
closely comparable to our 98.4%.
In a recently published comparison between manual and
automatically generated data for all cancer sites in the
Venetian Cancer registry (Italy) [8] concordance was
93.3%. This registry was the first in Europe to use an auto-
matic procedure for cancer incidence generation, and it is
reassuring that our concordance level was similar to that
obtained by this pioneering approach. The Venetian study
used a re-abstraction technique. Although re-abstraction
is an excellent method for verifying the accuracy of cancer
registration check on a routine basis, in part because it
requires limited resources, it is not ideal for evaluating
new data collection. We believe that a method that exam-
ines all incident cases of a defined time period is more
appropriate. We considered a whole year's incidence
which provides the opportunity to assess the efficacy of
the automated procedure for rare cancer sites.
Table 2: ICD-9 site code discrepancies between automatically 
accepted cases in comparison to manually generated cases.
Type of discrepancy No. %
Primary neoplasm coded:
With different primary site code 28 57
As metastases or unspecified neoplasm 17 35
As neoplasm of uncertain behaviour 1 2
Ill-defined neoplasm coded as:
Primary neoplasm 1 2
Metastases 0 0
Uncertain behaviour coded as
Primary neoplasm 2 4
TOTAL 49 100
Table 1: Identifying and demographic data discrepancies in 
automatically accepted cases in comparison to manually 
generated cases.
Type of discrepancy No. %
Surname
Surname spelling 45 1.50
Double surname ambiguity 4 0.14
First name
Spelling of first name 32 1.10
Double first name ambiguity 49 1.70
Sex
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First level analysis
Identifying and demographic data
Our low rate of surname discrepancies (1.6%) is similar to
the 2% found by Doebbeling et al. [15], and the 2.8% dis-
crepancy rate for first names is not too dissimilar to the
4% found in the same study. The study of Brewster et al.
in Scotland [16] found a discrepancy of only 0.3% in sur-
names and first names. Our figure for date of birth dis-
crepancies (1.2%) is lower than reported by Doebbeling
et al. (3%) and similar to that of Brewster et al. (1.3 %).
Site discrepancies
Our discrepancy rate of 1.6% for automatically accepted
cases in comparison with manual registration seems reas-
suring. Rates reported by other studies have generally
been higher (5.4% by Brewster et al. [16], 6% by Lapham
et al. [17], 20% by Phekoo et al. [18] in a sample of
hematopoietic cancers, and 7% by Dickinson et al. [19]).
However, these studies used disparate selection criteria.
For example in the study of Phekoo et al. 20% of disagree-
ments concerned morphological coding, so comparison is
not straightforward.
Predictably, more than half of our site discrepancies were
found, on comparison with manually generated data, to
use a generic code instead of a specific code for site, sub-
site, or histological subtype (the latter for hematologic
malignancies). For most of the remaining cases the auto-
matically generated record contained a metastatic code
only, obtained from the hospital discharge or pathology
files, while the manually-produced data contained a spe-
cific site code. This occurred because the manual method
Table 4: Problems in cases flagged for checking (selected cancer sites).
Type of Problem No. of cases with specific problems/total flagged cases for cancer site *
ICD-9 code 140–149 158,159 170,171 172 179–184 194 195–199 200–202 204–208
Cases notified by one source code only 3/63 6/14 2/13 22/45 32/139 3/7 9/73 20/83 21/43
Discordant Codes
Within a single organ system 25/63 8/14 2/13 0/45 40/139 0/7 16/73 72/83 21/43
Within more than one organ system but not multiple 
primaries
33/63 0/14 9/13 22/45 65/139 4/7 48/73 3/83 0/43
Multiple primary cancers 33/63 0/14 1/13 1/45 13/139 0/7 0/73 3/83 1/43
Extranodal/nodal site discrepancy 0/63 0/14 0/13 0/45 0/139 0/7 0/73 17/83 0/43
*A case may have more than one problem
Table 3: Percentages total cases accepted automatically for each site (%).
Site ICD-9 code Percentage accepted automatically (%)
Oropharyngeal sites 140–149 25
Digestive tract 150–154 66
155–157 66
158,159 22
Respiratory tract 160–161 71
162 77
163 50
Bone and soft tissue 170,171 50
Melanoma 172 50
Skin (non-melanoma) 173 77
Breast 174 83
Female genital tract 179–184 40
Prostate 185 77
Male genital tract 186,187 71
Urinary tract 188,189 62
Eye 190 38
Central nervous system 191,192 59
Thyroid gland 193 83




Other, met. and ill-defined sites 195–199 13
A high percentage indicates that very few cases had to be checked manually.Population Health Metrics 2006, 4:10 http://www.pophealthmetrics.com/content/4/1/10
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involved inspection of the entire clinical record that
includes the patient's history and laboratory test results
providing information on the site of origin and histology
from which the more specific code can be obtained.
Second level analysis
Site discrepancies
In our study the majority of coding discrepancies for site
arose through differences in the specificity of coding from
one source to another. This could arise, for example in
hematologic malignancies, if the disease was initially
coded as leukaemia (code 204) on the hospital discharge
file, but following histological analysis (reported on the
pathology file) it was found to be lymphoma (code 202).
For lymphomas, discrepancies also arose because extra-
nodal codes were used on one source, while on another
source file the more correct generic code was used. Thus, a
lymphoma arising in the stomach with characteristics of
an extranodal lymphoma could be coded as lymphoma
(202) on one source, but stomach cancer (151) on
another. Such cases accounted for 20% of the hematolog-
ical cancers rejected by the automatic system and flagged
for manual checking. This revealed an important limit of
the automatic system, which cannot be overcome by pro-
gramming but requires more consistent coding by staff
responsible for source record generation. On the other
hand, the fact that such cases were blocked by the auto-
matic system shows that it functioned correctly.
Problems of coding hematologic cancers were also raised
by Phekoo et al. [18] who compared the diagnostic accu-
racy of hematologic subtypes obtained from two manual
cancer registries, and found that 20% of the examined
cases had discordant diagnoses.
A high proportion of oropharyngeal cancer cases were
also blocked by our automatic system. The main reason
for this was that each specific site code defines a small area
that often merges imperceptibly with an adjacent area, so
that cancer may be coded for differing, anatomically-close
sites, depending on whether the diagnostic approach was
clinical or pathological; e.g. tonsillar pillar cancer extend-
ing to the palatine plate may be coded as 146 (tonsillar
pillars) or 145 (palatine). Such coding difficulties also
raise the problem of deciding whether the different site
codes indicate the presence of multiple primaries or a sin-
gle cancer that had extended to other sites. Our approach
to addressing this problem when programming Open
Registry was to retain information: for two primary sites to
be reported in a single individual, the sites had to differ at
the level of the third ICD-9 digit and in histology accord-
ing to the Berg classification [20]. The Berg classification
is used by all cancer registries to help ensure that the inci-
dence data they produced are mutually comparable.
The multiple primary versus extended cancer dilemma
was particularly evident for cancers of the lip, oral cavity,
and pharynx (codes 140–149) where over half of the dis-
crepancies arose for this reason. Middleton et al. [21] have
also commented on the difficulties of differentiating on
electronic data sources multiple primaries from extended
cancers.
We found a relatively high frequency of discrepancies
involving cancer from unknown primary site. Hospital
discharge files in particular often contained the undefined
code 199. In 66% of these cases this code was accompa-
nied by specific site codes, but in all cases manual check-
ing showed that the site codes were for metastatic or
disseminated cancers, and it was never possible to identify
the site of origin of the primary disease.
In the audit study to assess data quality in the Limberg
cancer registry (The Netherlands) [22], it was noted that
discrepant cases often involved undefined site codes. The
authors proposed as an explanation that 199 was often a
preliminary coding, which was later corrected by a more
specific code. Another suggested explanation was that the
surgeons or clinicians who complete the hospital dis-
charge files had a treatment-centered approach to coding,
while registry personnel were interested in precision and
natural history.
For genital tract cancers, coding discrepancies were often
due to the well-recognized problem of metastases often
having different histological characteristics from the pri-
mary, and the difficulty of distinguishing metastasis from
a second primary. Peritoneal carcinomatosis was often
coded as general carcinomatosis (code 199) or malignant
peritoneal neoplasm (code 158), and was thus discordant
with the primary ovarian (code 183) or uterine (code
182) cancer which gave rise to it. Malignant masses in the
abdomen/pelvis were often coded as ill-defined-site
within digestive organs and peritoneum (code 159) or as
colon or rectal cancer (153 or 154), instead of arising
from the female genital tract.
We found that other and ill-defined sites (code 195), per-
itoneum and ill-defined digestive tract (158 and 159),
bone (170) and soft tissue (171) were the sites that most
often required manual checking. This is not surprising as
these sites give problems for manual registration most
often. Similarly, it was reassuring that most other sites
were rarely flagged by the automatic system, which was
consistent with our manual coding experience that most
sites rarely give rise to coding problems.
Conclusion
In conclusion, the automated method of cancer registra-
tion recently introduced for the LCR has been shown toPopulation Health Metrics 2006, 4:10 http://www.pophealthmetrics.com/content/4/1/10
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produce good quality data in comparison with the man-
ual method. Since 59% of cases were accepted automati-
cally and contained relatively few and mostly trivial
discrepancies, the automatic procedure is efficient for rou-
tine case generation effectively cutting the workload
required by this amount. Since cancer registries will con-
tinue to operate on restricted budgets, it is important that
as much registration processing as possible is performed
automatically without compromising dataset quality,
which thereby frees manpower resources to the more
pressing problems of shortening the lag between the
acquisition of data and the publication of analyses. It is
likely that the feasibility and efficiency of automated reg-
istration will improve in the future as health care source
data become increasingly available in electronic form.
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